<DOC>
<DOCNO>
EP-0012361
</DOCNO>
<TEXT>
<DATE>
19800625
</DATE>
<IPC-CLASSIFICATIONS>
A61P-3/06 C07D-239/48 C07D-403/04 C07D-239/00 C07D-403/12 C07D-403/00 <main>C07D-403/04</main> C07D-405/00 A61K-31/505 A61P-3/00 C07D-405/12 A61P-3/04 C07D-405/14 A61K-31/415 
</IPC-CLASSIFICATIONS>
<TITLE>
amino-pyrimidine-carbanilides, process for their preparation, medicines containing them.
</TITLE>
<APPLICANT>
hoechst agde <sep>hoechst aktiengesellschaft <sep>hoechst aktiengesellschaft65926 frankfurt am mainde<sep>hoechst aktiengesellschaft<sep>
</APPLICANT>
<INVENTOR>
granzer ernold dr<sep>kampe klaus-dieter dr<sep>granzer, ernold, dr.<sep>kampe, klaus-dieter, dr.<sep>granzer, ernold, dr.falkensteiner strasse 24d-6233 kelkheim (taunus)de<sep>kampe, klaus-dieter, dr.am rehsteig 1d-6232 bad soden am taunusde<sep>granzer, ernold, dr.<sep>kampe, klaus-dieter, dr.<sep>granzer, ernold, dr.falkensteiner strasse 24d-6233 kelkheim (taunus)de<sep>kampe, klaus-dieter, dr.am rehsteig 1d-6232 bad soden am taunusde<sep>
</INVENTOR>
<ABSTRACT>
4-amino-2-neido- (or -thioureido) pyrimidine-5-car bonsorananilides of the general formula I, wherein the substituents R¹ to R⁸ and N have the meanings given as such or in the form of their physiologically acceptable acid addition salts valuablePharmacological properties have, methods for their preparation, pharmaceutical preparations based on the acid compounds and their use as a medicinal cell, in particular in the treatment of obesity and lipid metabolic disorders.The invention further relates to 2,4-diamino-pyrimidine-5-carbanilides of the general for Mel V which can be used for the preparation of compounds of formula I ver, and methods for their manufacturers.
</ABSTRACT>
</TEXT>
</DOC>
